Cambridge Investment Research Advisors, Inc. Dynavax Technologies Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,290 shares of DVAX stock, worth $140,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,290

Previous 11,290 -0.0%

Holding current value

$140,221

Previous $127,000 0.79%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$10.73 - $12.58 $11,534 - $13,523	-1,075 Reduced 8.69%	11,290 $127,000
Q4 2023 Feb 09, 2024	BUY	$13.09 - $14.98 $161,857 - $185,227	12,365 New	12,365 $173,000
Q1 2023 May 11, 2023	SELL	$9.44 - $11.88 $18,880 - $23,760	-2,000 Reduced 15.24%	11,125 $109,000
Q3 2022 Oct 17, 2022	SELL	$9.93 - $17.44 $10,277 - $18,050	-1,035 Reduced 7.31%	13,125 $137,000
Q2 2022 Jul 13, 2022	BUY	$7.45 - $12.83 $2,607 - $4,490	350 Added 2.53%	14,160 $178,000
Q1 2022 May 12, 2022	SELL	$9.75 - $14.44 $15,600 - $23,104	-1,600 Reduced 10.38%	13,810 $149,000
Q4 2021 Feb 03, 2022	SELL	$13.17 - $20.94 $18,556 - $29,504	-1,409 Reduced 8.38%	15,410 $216,000
Q3 2021 Nov 02, 2021	SELL	$9.16 - $19.83 $56,645 - $122,628	-6,184 Reduced 26.88%	16,819 $323,000
Q2 2021 Aug 10, 2021	SELL	$7.25 - $10.99 $123,250 - $186,830	-17,000 Reduced 42.5%	23,003 $226,000
Q1 2021 May 07, 2021	SELL	$4.57 - $11.18 $47,985 - $117,390	-10,500 Reduced 20.79%	40,003 $393,000
Q4 2020 Feb 04, 2021	SELL	$3.73 - $5.6 $18,452 - $27,703	-4,947 Reduced 8.92%	50,503 $224,000
Q3 2020 Oct 29, 2020	BUY	$4.32 - $11.7 $38,880 - $105,300	9,000 Added 19.38%	55,450 $239,000
Q2 2020 Jul 27, 2020	BUY	$2.94 - $9.1 $34,692 - $107,380	11,800 Added 34.05%	46,450 $412,000
Q1 2020 May 08, 2020	SELL	$2.27 - $6.2 $6,866 - $18,755	-3,025 Reduced 8.03%	34,650 $122,000
Q4 2019 Feb 04, 2020	SELL	$3.46 - $6.93 $4,152 - $8,316	-1,200 Reduced 3.09%	37,675 $215,000
Q3 2019 Nov 06, 2019	SELL	$2.69 - $4.85 $2,690 - $4,850	-1,000 Reduced 2.51%	38,875 $139,000
Q2 2019 Aug 15, 2019	SELL	$3.65 - $7.89 $10,950 - $23,670	-3,000 Reduced 7.0%	39,875 $0
Q1 2019 May 08, 2019	SELL	$7.08 - $12.09 $2,194 - $3,747	-310 Reduced 0.72%	42,875 $0
Q4 2018 Feb 05, 2019	SELL	$8.14 - $13.28 $12,210 - $19,920	-1,500 Reduced 3.36%	43,185 $395,000
Q3 2018 Nov 02, 2018	BUY	$11.85 - $16.0 $529,517 - $714,960	44,685 New	44,685 $0

Others Institutions Holding DVAX

# of Institutions

274

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Dynavax Technologies Corp Transaction History